Can Vraylar (cariprazine) be taken at night?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Vraylar Be Taken at Night?

Yes, Vraylar (cariprazine) can be taken at night, as the FDA-approved prescribing information explicitly states it "can be taken with or without food" once daily, with no specified time-of-day requirement. 1

Timing Flexibility

  • Vraylar is administered once daily with complete flexibility regarding timing. The official FDA labeling provides no restrictions on morning versus evening dosing, allowing patients and clinicians to choose based on individual tolerability patterns. 1

  • The medication can be taken at any consistent time of day that works best for the patient. This flexibility is particularly valuable given cariprazine's unique pharmacokinetic profile. 1

Key Pharmacokinetic Considerations

  • Cariprazine has an exceptionally long half-life of 7-8 days (including active metabolites), reaching steady state in 4-8 weeks. 2 This extended duration means that the specific time of day you take it has minimal impact on overall drug levels or therapeutic effect.

  • Changes in dosing will not be fully reflected in plasma concentrations for several weeks. 1 This long half-life actually makes timing less critical than with shorter-acting medications.

Practical Dosing Considerations

Choose nighttime dosing if:

  • The patient experiences daytime sedation or somnolence (though cariprazine is less prone to sedation compared to other antipsychotics) 2
  • The patient finds it easier to remember medication at bedtime

Choose morning dosing if:

  • The patient experiences insomnia (which occurs in ≥5% of patients at twice the rate of placebo, with potential dose-dependent effects) 3
  • Akathisia is problematic and daytime activity helps manage restlessness 2, 3

Important Safety Note

  • Monitor patients for adverse reactions and treatment response for several weeks after starting Vraylar and after each dosage change, regardless of timing. 1 The long half-life means late-occurring adverse reactions may not appear until several weeks after initiation. 1

  • Cariprazine causes more akathisia than aripiprazole or brexpiprazole but is less prone to insomnia, weight gain, and sedation overall. 2 If insomnia becomes problematic with evening dosing, switching to morning administration is reasonable.

References

Research

Cariprazine: A new partial dopamine agonist with a familiar profile.

Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2022

Related Questions

Is temperature dysregulation a normal side effect of Vraylar (cariprazine)?
Can an SNRI be safely combined with Vraylar (cariprazine), and what dosing and monitoring considerations are recommended?
Is it safe to start Vraylar (cariprazine) in a 61-year-old female with a history of seizures and severe anhedonia?
Is it safe to take cariprazine in the morning for a patient who consumes alcohol?
How to manage nausea in patients taking Vraylar (cariprazine)?
What are the differential diagnoses for a bleeding umbilical hernia in a patient who cannot undergo surgical repair due to comorbidities and who has scabs and ulcerations?
In a patient with B‑cell lymphoma who recently completed chemotherapy, now has severe neutropenia (white blood cell count 0.4 ×10³/µL, absolute neutrophil count 0.09 ×10³/µL) and an abdominal mass while off antibiotics, what empiric antimicrobial regimen and additional management steps are recommended?
How should I manage a 74-year-old woman with resistant hypertension (BP 158/86 mmHg) who is already on clopidogrel, amlodipine, losartan, metoprolol, and hydrochlorothiazide after an episode of severe hypertension with transient visual changes?
Is an elevated thyroid-stimulating hormone (TSH) level indicative of hypothyroidism?
What is the appropriate work‑up and management for a patient with a thyroid nodule on ultrasound, normal TSH, and exertional shortness of breath?
In a seizure‑free patient taking phenytoin 300 mg in the morning and 200 mg in the evening, lamotrigine 100 mg twice daily, and clobazam 10 mg at bedtime, should phenytoin serum concentrations be monitored?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.